Forbes December 23, 2024
Christian Espinosa

Blue Goat Cyber Founder. Veteran. Medical Device Cybersecurity Expert. Keynote Speaker. Author. 24x Ironman Finisher. Blood Clot Survivor.

In 2023, the Food and Drug Administration (FDA) took a more active approach to medical device cybersecurity. They issued new requirements for premarket submission and ongoing monitoring by medical device manufacturers. Additionally, Congress codified more stringent controls to prevent cyberattacks in 2022, which took effect in March 2023.

While these rules have not been in place for long, many still wonder: Are they working?

Stricter rules are driving prevention, but challenges persist.

The requirement to adapt to these new rules and regulations is good for manufacturers in several ways. Minimizing the risk of exploitation ensures that their products remain safe and secure...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Medical Devices
Related Articles:
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article